SAFC Completes API Facility Expansion

SAFC, a member of the Sigma-Aldrich Group, has completed a $12 million expansion program at its high potency advanced pharma intermediates (API) facility in Madison, WI. The 38,000-sq.-ft. expansion more than doubles the size of the company’s existing 23,500 sq.-ft. building and its cGMP manufacturing capacity at Madison.

The two-story infrastructure adds new analytical laboratories, expanded R&D laboratories, three new kilo laboratories, a hydrogenation suite, cGMP drying suite and increased warehousing and storage capacity. The expansion has been driven by an increase in demand for custom chemical manufacturing services for highly potent APIs, including category III and category IV compounds.

“Our Madison expansion enhances our ability to provide unparalleled service in the high potency API manufacturing market,” said Frank Wicks, president of SAFC. “The additional capability allows us to continue to grow our high potency business and provides resources to anticipate the needs of current and future customers,” he added.